Literature DB >> 26167244

Is there a role for adaptive immunity in nonalcoholic steatohepatitis?

Salvatore Sutti1, Aastha Jindal1, Stefania Bruzzì1, Irene Locatelli1, Cristina Bozzola1, Emanuele Albano1.   

Abstract

The growing diffusion of nonalcoholic fatty liver disease (NAFLD) is a consequence of the worldwide increase in the prevalence of obesity. Oxidative stress is widely recognized to play a pivotal role in NAFLD evolution to nonalcoholic steatohepatitis (NASH). Here we review recent evidence suggesting that oxidative stress-derived antigens originating within fatty livers stimulate both humoral and cellular adaptive immune responses and the possible mechanisms involved in sustaining hepatic inflammation in NASH.

Entities:  

Keywords:  Adaptive immunity; Hepatic inflammation; Liver; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis

Year:  2015        PMID: 26167244      PMCID: PMC4491900          DOI: 10.4254/wjh.v7.i13.1725

Source DB:  PubMed          Journal:  World J Hepatol


  48 in total

1.  N-acetylcysteine attenuates progression of liver pathology in a rat model of nonalcoholic steatohepatitis.

Authors:  January N Baumgardner; Kartik Shankar; Leah Hennings; Emanuele Albano; Thomas M Badger; Martin J J Ronis
Journal:  J Nutr       Date:  2008-10       Impact factor: 4.798

2.  Natural killer and natural killer T cells in liver fibrosis.

Authors:  Bin Gao; Svetlana Radaeva
Journal:  Biochim Biophys Acta       Date:  2012-09-26

3.  Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice.

Authors:  Fanli Meng; Kai Wang; Tomonori Aoyama; Sergei I Grivennikov; YongHan Paik; David Scholten; Min Cong; Keiko Iwaisako; Xiao Liu; Mingjun Zhang; Christoph H Österreicher; Felix Stickel; Klaus Ley; David A Brenner; Tatiana Kisseleva
Journal:  Gastroenterology       Date:  2012-06-08       Impact factor: 22.682

Review 4.  Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace.

Authors:  György Baffy; Elizabeth M Brunt; Stephen H Caldwell
Journal:  J Hepatol       Date:  2012-02-09       Impact factor: 25.083

5.  CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity.

Authors:  Satoshi Nishimura; Ichiro Manabe; Mika Nagasaki; Koji Eto; Hiroshi Yamashita; Mitsuru Ohsugi; Makoto Otsu; Kazuo Hara; Kohjiro Ueki; Seiryo Sugiura; Kotaro Yoshimura; Takashi Kadowaki; Ryozo Nagai
Journal:  Nat Med       Date:  2009-07-26       Impact factor: 53.440

6.  Interplay between oxidative stress and immunity in the progression of alcohol-mediated liver injury.

Authors:  Matteo Vidali; Stephen F Stewart; Emanuele Albano
Journal:  Trends Mol Med       Date:  2008-01-25       Impact factor: 11.951

Review 7.  Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications.

Authors:  Elisa Fabbrini; Shelby Sullivan; Samuel Klein
Journal:  Hepatology       Date:  2010-02       Impact factor: 17.425

8.  Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model.

Authors:  Atul Sahai; Padmini Malladi; Hector Melin-Aldana; Richard M Green; Peter F Whitington
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-03-25       Impact factor: 4.052

9.  Kupffer cell and interleukin-12-dependent loss of natural killer T cells in hepatosteatosis.

Authors:  Michael Kremer; Emmanuel Thomas; Richard J Milton; Ashley W Perry; Nico van Rooijen; Michael D Wheeler; Steven Zacks; Michael Fried; Richard A Rippe; Ian N Hines
Journal:  Hepatology       Date:  2010-01       Impact factor: 17.425

10.  Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis.

Authors:  Wing-Kin Syn; Steve S Choi; Evaggelia Liaskou; Gamze F Karaca; Kolade M Agboola; Ye Htun Oo; Zhiyong Mi; Thiago A Pereira; Marzena Zdanowicz; Padmini Malladi; Yuping Chen; Cynthia Moylan; Youngmi Jung; Syamal D Bhattacharya; Vanessa Teaberry; Alessia Omenetti; Manal F Abdelmalek; Cynthia D Guy; David H Adams; Paul C Kuo; Gregory A Michelotti; Peter F Whitington; Anna Mae Diehl
Journal:  Hepatology       Date:  2010-10-21       Impact factor: 17.425

View more
  9 in total

Review 1.  Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammation.

Authors:  Samar H Ibrahim; Petra Hirsova; Gregory J Gores
Journal:  Gut       Date:  2018-01-24       Impact factor: 23.059

2.  Role of FXR in Liver Inflammation during Nonalcoholic Steatohepatitis.

Authors:  Laura E Armstrong; Grace L Guo
Journal:  Curr Pharmacol Rep       Date:  2017-02-21

3.  Jiang Tang Xiao Ke Granule, a Classic Chinese Herbal Formula, Improves the Effect of Metformin on Lipid and Glucose Metabolism in Diabetic Mice.

Authors:  Yi Zhang; Hong An; Si-Yuan Pan; Dan-Dan Zhao; Jia-Cheng Zuo; Xiao-Ke Li; Ya Gao; Qian-Qian Mu; Na Yu; Yue Ma; Fang-Fang Mo; Si-Hua Gao
Journal:  Evid Based Complement Alternat Med       Date:  2016-06-21       Impact factor: 2.629

Review 4.  Insights into the Role and Interdependence of Oxidative Stress and Inflammation in Liver Diseases.

Authors:  Sha Li; Ming Hong; Hor-Yue Tan; Ning Wang; Yibin Feng
Journal:  Oxid Med Cell Longev       Date:  2016-12-14       Impact factor: 6.543

Review 5.  Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity.

Authors:  Carlos J Pirola; Silvia Sookoian
Journal:  World J Gastroenterol       Date:  2018-04-21       Impact factor: 5.742

6.  High Prevalence of Autoimmune Gastritis in Patients with Nonalcoholic Steatohepatitis.

Authors:  Miwa Kawanaka; Tomohiro Tanikawa; Tomoari Kamada; Katusinori Ishii; Noriyo Urata; Jun Nakamura; Ken Nishino; Mitsuhiko Suehiro; Takako Sasai; Noriaki Manabe; Yasumasa Monobe; Hirofumi Kawamoto; Ken Haruma
Journal:  Intern Med       Date:  2019-07-10       Impact factor: 1.271

7.  KLF10 Deficiency in CD4+ T Cells Triggers Obesity, Insulin Resistance, and Fatty Liver.

Authors:  Akm Khyrul Wara; Shijia Wang; Chun Wu; Fang Fang; Stefan Haemmig; Brittany N Weber; Ceren O Aydogan; Yevgenia Tesmenitsky; Hassan Aliakbarian; John R Hawse; Malayannan Subramaniam; Lei Zhao; Peter T Sage; Ali Tavakkoli; Amanda Garza; Lydia Lynch; Alexander S Banks; Mark W Feinberg
Journal:  Cell Rep       Date:  2020-12-29       Impact factor: 9.423

8.  A Mineralocorticoid Receptor Deficiency in Myeloid Cells Reduces Liver Steatosis by Impairing Activation of CD8+ T Cells in a Nonalcoholic Steatohepatitis Mouse Model.

Authors:  Natalia Muñoz-Durango; Marco Arrese; Alejandra Hernández; Evelyn Jara; Alexis M Kalergis; Daniel Cabrera
Journal:  Front Immunol       Date:  2020-12-16       Impact factor: 7.561

9.  Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis.

Authors:  Kirstine S Tølbøl; Maria Nb Kristiansen; Henrik H Hansen; Sanne S Veidal; Kristoffer Tg Rigbolt; Matthew P Gillum; Jacob Jelsing; Niels Vrang; Michael Feigh
Journal:  World J Gastroenterol       Date:  2018-01-14       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.